Intranasal delivery of growth differentiation factor 5 to the central nervous system

Author： Hanson Leah R.   Fine Jared M.   Hoekman John D.   Nguyen Thuhien M.   Burns Rachel B.   Martinez Paula M.   Pohl Jens   Frey William H.  

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.19, Iss.3, 2012-04, pp. : 149-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 510-526

Bentham Science Publishers

Access to resources Recommend Favorite

Intranasal Treatment of Central Nervous System Dysfunction in Humans

By Chapman Colin   Frey William   Craft Suzanne   Danielyan Lusine   Hallschmid Manfred   Schiöth Helgi   Benedict Christian  

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2475-2484

Springer Publishing Company

Access to resources Recommend Favorite

Effects of basic fibroblast growth factor on central nervous system functions

By Abe K.   Saito H.  

Pharmacological Research, Vol. 43, Iss. 4, 2001-04 ,pp. : 307-312

Academic Press

Access to resources Recommend Favorite

Current Approaches for Drug Delivery to Central Nervous System

By  

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 389-397

Bentham Science Publishers

Access to resources Recommend Favorite

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite